PON2 (Paraoxonase 2)

Migration, Crosslink

📖

PON2 (Paraoxonase 2)

active

wiki page Created: 2026-04-02T07:19:18 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-pon2

📖 Wiki Page

gene2573 wordssynced 2026-04-02

PON2 (Paraoxonase 2)

Introduction

The PON2 gene encodes paraoxonase 2 (PON2), a unique intracellular enzyme with diverse physiological functions that have garnered significant attention in neurodegenerative disease research. Unlike its well-studied relative PON1, which circulates in plasma associated with high-density lipoprotein (HDL), PON2 is primarily an intracellular enzyme residing in the endoplasmic reticulum (ER), mitochondria, and nuclear envelope.[@f2021] This distinctive subcellular localization positions PON2 at critical intersections of cellular metabolism, where it exerts potent antioxidant, anti-apoptotic, and anti-inflammatory effects that directly impact neuronal survival and function.

The paraoxonase gene family consists of three members—PON1, PON2, and PON3—all located on chromosome 7q21.3 in humans in a tandem arrangement.[@k2022] While PON1 and PON3 are primarily expressed in the liver and secreted into the plasma, PON2 exhibits a broader tissue distribution with particularly high expression in the brain, lung, and heart. In the central nervous system, PON2 is expressed in neurons and glia, where it serves as a frontline defender against oxidative stress—a hallmark feature of neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD).

...

PON2 (Paraoxonase 2)

Introduction

The PON2 gene encodes paraoxonase 2 (PON2), a unique intracellular enzyme with diverse physiological functions that have garnered significant attention in neurodegenerative disease research. Unlike its well-studied relative PON1, which circulates in plasma associated with high-density lipoprotein (HDL), PON2 is primarily an intracellular enzyme residing in the endoplasmic reticulum (ER), mitochondria, and nuclear envelope.[@f2021] This distinctive subcellular localization positions PON2 at critical intersections of cellular metabolism, where it exerts potent antioxidant, anti-apoptotic, and anti-inflammatory effects that directly impact neuronal survival and function.

The paraoxonase gene family consists of three members—PON1, PON2, and PON3—all located on chromosome 7q21.3 in humans in a tandem arrangement.[@k2022] While PON1 and PON3 are primarily expressed in the liver and secreted into the plasma, PON2 exhibits a broader tissue distribution with particularly high expression in the brain, lung, and heart. In the central nervous system, PON2 is expressed in neurons and glia, where it serves as a frontline defender against oxidative stress—a hallmark feature of neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD).

Research over the past two decades has established PON2 as a critical determinant of neuronal fate under conditions of oxidative stress.[@l2019] Loss of PON2 function sensitizes cells to oxidative damage, accelerates mitochondrial dysfunction, and promotes apoptotic cell death. Conversely, PON2 overexpression protects against various toxic insults, including amyloid-beta (Aβ) toxicity, mitochondrial toxins, and ER stress. These findings have positioned PON2 as both a biomarker of cellular stress and a potential therapeutic target for neurodegenerative conditions.

Gene Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#1a5f7a;color:white;">PON2 (Paraoxonase 2)</th></tr>
<tr><td>Gene Symbol</td><td>PON2</td></tr>
<tr><td>Full Name</td><td>Paraoxonase 2</td></tr>
<tr><td>Chromosomal Location</td><td>7q21.3</td></tr>
<tr><td>NCBI Gene ID</td><td>[5445](https://www.ncbi.nlm.nih.gov/gene/5445)</td></tr>
<tr><td>OMIM</td><td>[602443](https://omim.org/entry/602443)</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000105855</td></tr>
<tr><td>UniProt ID</td><td>[Q15165](https://www.uniprot.org/uniprot/Q15165)</td></tr>
<tr><td>Protein Length</td><td>354 amino acids</td></tr>
<tr><td>Tissue Distribution</td><td>Brain, lung, heart, liver, kidney</td></tr>
<tr><td>Associated Diseases</td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), [Atherosclerosis](/diseases/atherosclerosis)</td></tr>
</table>
</div>

Protein Structure and Biochemistry

Structural Features

PON2 is a 354-amino acid protein with several distinctive structural features:

N-terminal signal sequence: Unlike secreted PON1 and PON3, PON2 lacks a classical secretory signal peptide, explaining its intracellular retention.
N-terminal hydrophobic domain: A hydrophobic N-terminal region anchors PON2 to intracellular membranes, particularly the endoplasmic reticulum and mitochondrial outer membrane.
N-glycosylation sites: PON2 contains multiple N-linked glycosylation sites that are important for proper folding and stability.
Lactonase active site: The canonical paraoxonase active site comprises a lactonase domain that hydrolyzes a broad range of substrates.
Conserved serine hydrolase motif: A serine-lysine-histidine catalytic triad typical of the paraoxonase family.

The three-dimensional structure of PON2 has been predicted through homology modeling based on crystallized family members.[@ea2024] The enzyme adopts a six-bladed β-propeller fold with a central tunnel housing the active site—a structure conserved across the paraoxonase family.

Enzymatic Activities

PON2 exhibits multiple enzymatic activities that contribute to its biological functions:

Lactonase Activity

The primary activity of PON2 is lactonase activity—the hydrolysis of lactones and oxidized lipid species:

Aryl lactones: Hydrolyzes various aromatic and aliphatic lactones.
Homocysteine thiolactone: Converts a toxic metabolite of homocysteine.
Quinone lactones: Detoxifies electrophilic quinone derivatives.
Oxidized phospholipids: Hydrolyzes oxidized phospholipid products formed during lipid peroxidation.

This lactonase activity is central to PON2's antioxidant function, as many oxidized lipid species are electrophilic lactones that damage cellular components.

Arylesterase Activity

PON2 possesses arylesterase activity:

Phenyl acetate hydrolysis: A standard substrate for measuring arylesterase activity.
Aryl esters: Hydrolyzes various aromatic esters.

Paraoxonase Activity

Unlike PON1, which has robust paraoxonase activity (hydrolyzing the toxic organophosphate metabolite paraoxon), PON2 exhibits minimal paraoxonase activity, suggesting distinct physiological substrates.

Subcellular Localization

PON2 exhibits a characteristic intracellular distribution:

Endoplasmic reticulum: The predominant localization, where PON2 participates in ER stress response and calcium homeostasis.
Mitochondria: Associated with the outer mitochondrial membrane, where it maintains mitochondrial integrity and prevents apoptosis.
Nuclear envelope: Recent studies suggest PON2 may interact with nuclear pore complexes.
Cytosol: A minor fraction exists in the soluble cytosolic compartment.

This strategic localization at membrane interfaces positions PON2 to directly interact with oxidative stress sources and coordinate cellular stress responses.

Biological Functions

Antioxidant Defense

PON2 serves as a crucial component of the cellular antioxidant defense system:

Oxidized Lipid Hydroxylation

PON2 hydrolyzes toxic oxidized lipid products:

4-hydroxynonenal (4-HNE): Detoxifies this reactive lipid peroxidation product that forms adducts with proteins, DNA, and lipids.
Malondialdehyde (MDA): Reduces levels of this reactive carbonyl compound.
Oxidized phospholipids: Hydrolyzes oxidized phospholipid species that accumulate during oxidative stress.
Cholesterol oxidation products: Processes oxidized cholesterol derivatives.

ROS Prevention

Beyond hydrolyzing oxidants, PON2 actively prevents their formation:

Superoxide reduction: Reduces superoxide generation at the mitochondrial membrane.
Peroxide decomposition: Catalyzes decomposition of lipid peroxides.
NADPH oxidase modulation: Inhibits superoxide production by NADPH oxidases.

Protection Against Lipid Peroidation

PON2 preserves cellular membrane integrity:

LDL oxidation prevention: Inhibits copper-induced LDL oxidation in vitro.
Membrane protection: Maintains plasma membrane fluidity and function.
Lipid raft stabilization: Preserves lipid raft organization important for signaling.

Anti-Apoptotic Function

PON2 is a potent inhibitor of mitochondrial apoptosis:

Mitochondrial Integrity

Membrane potential maintenance: Preserves mitochondrial membrane potential (Δψm).
Respiratory chain protection: Protects electron transport chain components from oxidative damage.
Mitochondrial morphology: Maintains normal mitochondrial ultrastructure.
mtDNA protection: Prevents mitochondrial DNA oxidation.

Apoptosis Pathway Inhibition

Caspase inhibition: Direct inhibition of caspase-3 and caspase-9 activation.
Bcl-2 family modulation: Promotes anti-apoptotic Bcl-2 family member expression.
Cytochrome c release prevention: Blocks mitochondrial cytochrome c release.
PARP cleavage inhibition: Prevents poly(ADP-ribose) polymerase cleavage.

Specific Protection Against Neurotoxins

Amyloid-beta toxicity: PON2 knockdown sensitizes neurons to Aβ-induced death.
MPP+ toxicity: Protects against mitochondrial toxin-induced dopaminergic neuron death.
6-OHDA toxicity: Prevents oxidative stress-induced neuronal apoptosis.
Rotenone toxicity: Maintains mitochondrial function despite complex I inhibition.

Endoplasmic Reticulum Stress Response

PON2 plays a critical role in ER homeostasis:

Unfolded protein response: Modulates UPR signaling to promote cell survival.
Calcium homeostasis: Regulates ER calcium store management.
ER-associated degradation (ERAD): Facilitates clearance of misfolded proteins.
CHOP regulation: Suppresses pro-apoptotic CHOP expression during ER stress.

Neuroinflammation Modulation

Emerging evidence indicates PON2 regulates neuroinflammation:

Microglial activation: Modulates microglial activation states toward anti-inflammatory phenotype.
Cytokine production: Reduces pro-inflammatory cytokine release (TNF-α, IL-1β, IL-6).
NF-κB inhibition: Interferes with NF-κB signaling pathway activation.
NLRP3 inflammasome: Modulates NLRP3 inflammasome activity.

Expression Pattern

Tissue Distribution

PON2 exhibits ubiquitous expression with notable variation:

Brain: Highest expression in neurons of hippocampus, cortex, and basal ganglia. Also expressed in astrocytes and microglia.
Lung: High expression in bronchial epithelial cells and alveolar macrophages.
Heart: Abundant in cardiac myocytes.
Liver: Moderate expression in hepatocytes.
Kidney: Expression in renal tubular cells.
Skeletal muscle: Moderate expression in muscle fibers.
Testis: Expression in spermatogenic cells.

Cellular Expression

Within the brain, PON2 is expressed in:

Neurons: Particularly susceptible populations including hippocampal CA1 pyramidal neurons, cortical pyramidal neurons, and dopaminergic neurons of the substantia nigra.
Astrocytes: Provides antioxidant protection for this abundant glial cell type.
Microglia: Modulates microglial activation and inflammatory responses.
Oligodendrocytes: Protects against oxidative damage in myelinating cells.

Regulation of Expression

PON2 expression is dynamically regulated:

Transcriptional activation: Oxidative stress, heat shock, and inflammatory cytokines induce PON2 expression.
Transcriptional repression: Certain disease states reduce PON2 expression.
Post-translational modification: Phosphorylation and glycosylation modulate activity.
Epigenetic regulation: DNA methylation and histone modifications influence expression.

Disease Associations

Alzheimer's Disease

Multiple lines of evidence implicate PON2 in AD pathogenesis:

Reduced PON2 Expression

Postmortem brains: AD brains show reduced PON2 expression in vulnerable regions.
Disease progression: PON2 reduction correlates with disease severity.
Animal models: AD mouse models exhibit decreased PON2.

Genetic Associations

SNP variants: Certain PON2 polymorphisms are associated with AD risk.
Haplotypes: Specific PON2 haplotypes modify disease susceptibility.

Mechanistic Links

Aβ toxicity: PON2 deficiency exacerbates Aβ-induced neuronal death.
Oxidative stress: PON2 loss increases oxidative markers in AD models.
Tau pathology: PON2 dysfunction may influence tau phosphorylation.
Synaptic dysfunction: PON2 deficiency impairs synaptic plasticity.

Therapeutic Implications

Enhancement strategies: Upregulating PON2 may protect neurons.
Biomarker potential: PON2 levels may serve as disease biomarkers.
Target validation: PON2 is a validated therapeutic target.

Parkinson's Disease

PON2 is equally important in PD:

Dopaminergic Neuron Protection

Substantia nigra: PON2 is highly expressed in dopaminergic neurons.
Vulnerability: Loss of PON2 renders these neurons more vulnerable.
α-Synuclein interaction: PON2 modulates α-synuclein aggregation.

Genetic Associations

Risk variants: PON2 polymorphisms modify PD risk.
Gene-environment interaction: PON2 variants interact with environmental risk factors.

Mechanistic Pathways

Mitochondrial protection: PON2 maintains mitochondrial function.
Oxidative stress: PON2 counteracts ROS in dopaminergic neurons.
Apoptosis prevention: Blocks mitochondrial apoptotic pathway.
Neuroinflammation: Modulates microglial activation.

Models and Evidence

MPTP models: PON2 knockout mice show enhanced vulnerability.
α-Synuclein models: PON2 deficiency accelerates pathology.
Postmortem studies: Reduced PON2 in PD substantia nigra.

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS)

Motor neurons show reduced PON2 expression.
PON2 polymorphisms may modify ALS risk.
Protects against oxidative stress in motor neurons.

Huntington's Disease

PON2 expression is altered in striatal neurons.
May modulate mutant huntingtin toxicity.
Genetic variants influence disease onset.

Multiple Sclerosis

PON2 levels are reduced in demyelinating lesions.
May contribute to oligodendrocyte vulnerability.
Therapeutic potential for promotion of remyelination.

Prion Diseases

PON2 is dysregulated in prion-infected brains.
May influence prion protein aggregation.
Potential therapeutic target.

Cardiovascular Disease

Beyond neurodegeneration, PON2 relates to:

Atherosclerosis: PON2 polymorphisms associate with cardiovascular disease risk.
Endothelial function: Protects endothelial cells from oxidative damage.
Ischemia-reperfusion injury: Limits tissue damage in stroke and myocardial infarction.

Molecular Mechanisms

Signaling Pathways

PON2 modulates multiple cellular signaling pathways:

Nrf2-ARE Pathway

Activation: PON2 contributes to Nrf2 transcription factor activation.
Antioxidant response: Enhances expression of phase II detoxifying enzymes.
Cellular adaptation: Promotes antioxidant gene expression.

PI3K/Akt Pathway

Survival signaling: PON2 promotes Akt phosphorylation.
Pro-survival effects: Mediates anti-apoptotic signaling.
Metabolic regulation: Modulates cellular metabolism.

MAPK Pathways

ERK activation: Modulates ERK1/2 signaling.
Stress kinases: Regulates JNK and p38 activation.
Cell fate decisions: Influences survival versus death decisions.

Protein Interactions

PON2 interacts with various proteins:

Heat shock proteins: Associates with Hsp70 and Hsp90.
Apoptotic proteins: Interacts with Bcl-2 family members.
Transcription factors: Modulates Nrf2 activity.
Mitochondrial proteins: Associates with respiratory chain complexes.

Regulation by Cellular State

Oxidative Stress Response

Induction: Oxidative stress upregulates PON2 expression.
Activation: Stress activates PON2 enzymatic function.
Adaptation: PON2 contributes to cellular adaptation.

Inflammatory Response

Cytokine regulation: TNF-α and IL-1β modulate PON2.
NF-κB interplay: Cross-talk between PON2 and NF-κB.
Microglial modulation: Affects microglial phenotype.

Regulation of PON2 Expression

Transcriptional Regulation

Promoter Elements

Antioxidant response elements (ARE): Nrf2 binding sites in promoter.
Heat shock elements (HSE): HSF1-responsive elements.
Cytokine-responsive elements: Inflammatory cytokine-responsive regions.

Transcription Factors

Nrf2: Primary regulator under oxidative stress.
NF-κB: Can both induce and repress PON2.
AP-1: Modulates basal expression.
SP1: Constitutive expression regulator.

Epigenetic Regulation

DNA Methylation

Promoter methylation: Alters transcription in disease states.
Tissue-specific patterns: Different methylation in various tissues.
Disease-associated changes: Aberrant methylation in neurodegeneration.

Histone Modifications

Acetylation: Active chromatin marks in promoter region.
Methylation: Context-dependent effects.
Therapeutic potential: Epigenetic drugs may modulate expression.

Post-Translational Regulation

Phosphorylation

Kinases: PKC and other kinases phosphorylate PON2.
Functional consequences: Modulates enzymatic activity.

Glycosylation

N-linked glycans: Affect stability and localization.
Quality control: Glycosylation ensures proper folding.

Therapeutic Implications

Target Validation

PON2 is a validated therapeutic target:

Protective effects: Overexpression protects neurons.
Pathogenic role: Deficiency exacerbates disease.
Enzyme activity: Correlation between activity and protection.

Therapeutic Strategies

Upregulation Approaches

Nrf2 activators: Compounds that enhance Nrf2 increase PON2.
Antioxidants: Direct oxidative stress induces PON2.
Epigenetic modulators: HDAC inhibitors may increase expression.

Direct Enzyme Activation

Small molecule activators: Direct PON2 agonists in development.
Substrate analogues: Lactone derivatives that stimulate activity.

Gene Therapy

Viral vectors: AAV-mediated PON2 expression.
Cell therapy: Stem cell-based delivery.
CRISPR activation: Epigenetic editing to increase expression.

Challenges and Considerations

Activity versus expression: Both matter for therapeutic benefit.
Tissue delivery: CNS delivery remains challenging.
Timing: Optimal intervention window unclear.
Biomarkers: Need companion biomarkers for patient selection.

Research Tools

Molecular Tools

Antibodies: Specific antibodies for detection.
Enzyme assays: Fluorometric and colorimetric lactonase assays.
Activity-based probes: Chemical probes for activity measurement.

Animal Models

Knockout mice: PON2-deficient mice show enhanced vulnerability.
Transgenic mice: Overexpression models.
Conditional knockouts: Tissue-specific ablation.

Cellular Models

Neuronal cultures: Primary neurons from various species.
Cell lines: Neuroblastoma lines (SH-SY5Y, PC12).
iPSC-derived neurons: Human patient-derived cells.

Cross-References

[PON1 (Paraoxonase 1)](../genes/pon1): Circulating paraoxonase with related functions
[PON3 (Paraoxonase 3)](../genes/pon3): Another family member with antioxidant function

[PON2 Protein](../proteins/pon2-protein): Detailed protein page

[Oxidative Stress in Neurodegeneration](../mechanisms/oxidative-stress-neurodegeneration): Broader context
[Mitochondrial Dysfunction in Parkinson's Disease](../mechanisms/mitochondrial-dysfunction-pd): Mitochondrial protection
[Amyloid Metabolism in AD](../mechanisms/app-amyloid-pathway-alzheimers): Aβ toxicity connection
[Alpha-Synuclein Pathology](../mechanisms/alpha-synuclein-pathway): PD connection
[Neuroinflammation Pathway](../mechanisms/neuroinflammation-pathway): Inflammation modulation

[Alzheimer's Disease](../diseases/alzheimers-disease): AD overview
[Parkinson's Disease](../diseases/parkinsons-disease-disease): PD overview

External Resources

Databases

[NCBI Gene: PON2](https://www.ncbi.nlm.nih.gov/gene/5445)
[UniProt: Q15165](https://www.uniprot.org/uniprot/Q15165)
[Ensembl: ENSG00000105855](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105855)
[OMIM: 602443](https://omim.org/entry/602443)
[GeneCards: PON2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PON2)

Brain Atlas Resources

[Allen Human Brain Atlas - PON2](https://human.brain-map.org/microarray/search/show?search_term=PON2)
[BrainSpan Atlas](https://www.brainspan.org/search?gene=PON2)

References

[Ng et al., Paraoxonase-2 modulates cellular response to oxidative stress, Free Radic Biol Med (2014)](https://pubmed.ncbi.nlm.nih.gov/25016030/)

[Witte et al., PON2 in neurodegeneration, Free Radic Biol Med (2011)](https://pubmed.ncbi.nlm.nih.gov/21684312/)

[Schweikert et al., PON2 deficiency leads to increased susceptibility to oxidative stress, J Biol Chem (2019)](https://pubmed.ncbi.nlm.nih.gov/30710018/)

[Devarajan et al., Mitochondrial paraoxonase-2 maintains mitochondrial integrity, Cell Death Differ (2018)](https://pubmed.ncbi.nlm.nih.gov/29323234/)

[Shiner et al., PON2 in Parkinson's disease models, Mov Disord (2017)](https://pubmed.ncbi.nlm.nih.gov/28767594/)

[Giusti et al., PON2 and Alzheimer's disease pathogenesis, J Alzheimers Dis (2020)](https://pubmed.ncbi.nlm.nih.gov/31903978/)

[Stoltz et al., Paraoxonase 2: a unique enzymatic activity and role in disease, Free Radic Biol Med (2009)](https://pubmed.ncbi.nlm.nih.gov/19447153/)

[Marsillach et al., PON2 in cellular stress response and antioxidant defense, Antioxid Redox Signal (2011)](https://pubmed.ncbi.nlm.nih.gov/21338346/)

[Horke et al., PON2 and the unfolded protein response, Cell Mol Neurobiol (2017)](https://pubmed.ncbi.nlm.nih.gov/27350139/)

[Liu et al., PON2 genetic variants and susceptibility to Alzheimer's disease, J Neurol Sci (2019)](https://pubmed.ncbi.nlm.nih.gov/31351673/)

[Zawrotek et al., PON2 polymorphisms and Parkinson's disease risk, Neuromolecular Med (2021)](https://pubmed.ncbi.nlm.nih.gov/33164121/)

[Benhamou et al., PON2 expression is modulated by oxidative stress, Oxid Med Cell Longev (2016)](https://pubmed.ncbi.nlm.nih.gov/27006662/)

[Morishima et al., PON2 protects neurons from mitochondrial apoptosis, Cell Mol Neurobiol (2020)](https://pubmed.ncbi.nlm.nih.gov/32157622/)

[Park et al., PON2 in neuroinflammation and microglial activation, J Neuroinflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/33743628/)

[Kim et al., PON2 deficiency exacerbates amyloid pathology, Mol Neurodegener (2018)](https://pubmed.ncbi.nlm.nih.gov/29669573/)

[Yang et al., PON2 and alpha-synuclein aggregation, Free Radic Biol Med (2019)](https://pubmed.ncbi.nlm.nih.gov/30684431/)

[Zhong et al., PON2 maintains dopaminergic neuron survival, Antioxidants (2016)](https://pubmed.ncbi.nlm.nih.gov/27754458/)

[Fujimura et al., PON2 as a therapeutic target in neurodegeneration, Pharmaceuticals (2020)](https://pubmed.ncbi.nlm.nih.gov/32244423/)

[Liu et al., Epigenetic regulation of PON2 expression, Epigenetics (2020)](https://pubmed.ncbi.nlm.nih.gov/32048543/)

[Wang et al., PON2 and lipid peroxidation in neurodegeneration, Lipids Health Dis (2018)](https://pubmed.ncbi.nlm.nih.gov/29690868/)

📖 View canonical wiki page →

Related Entities

PON2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-pon2
kg_node_id	PON2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-47d9e7b053fb
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-pon2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

60%

Debates

0

Incoming

12

Outgoing

23

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

PON2 (Paraoxonase 2)

PON2 (Paraoxonase 2)

Introduction

PON2 (Paraoxonase 2)

Introduction

Gene Overview

Protein Structure and Biochemistry

Structural Features

Enzymatic Activities

Lactonase Activity

Arylesterase Activity

Paraoxonase Activity

Subcellular Localization

Biological Functions

Antioxidant Defense

Oxidized Lipid Hydroxylation

ROS Prevention

Protection Against Lipid Peroidation

Anti-Apoptotic Function

Mitochondrial Integrity

Apoptosis Pathway Inhibition

Specific Protection Against Neurotoxins

Endoplasmic Reticulum Stress Response

Neuroinflammation Modulation

Expression Pattern

Tissue Distribution

Cellular Expression

Regulation of Expression

Disease Associations

Alzheimer's Disease

Reduced PON2 Expression

Genetic Associations

Mechanistic Links

Therapeutic Implications

Parkinson's Disease

Dopaminergic Neuron Protection

Genetic Associations

Mechanistic Pathways

Models and Evidence

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Multiple Sclerosis

Prion Diseases

Cardiovascular Disease

Molecular Mechanisms

Signaling Pathways

Nrf2-ARE Pathway

PI3K/Akt Pathway

MAPK Pathways

Protein Interactions

Regulation by Cellular State

Oxidative Stress Response

Inflammatory Response

Regulation of PON2 Expression

Transcriptional Regulation

Promoter Elements

Transcription Factors

Epigenetic Regulation

DNA Methylation

Histone Modifications

Post-Translational Regulation

Phosphorylation

Glycosylation

Therapeutic Implications

Target Validation

Therapeutic Strategies

Upregulation Approaches

Direct Enzyme Activation

Gene Therapy

Challenges and Considerations

Research Tools

Molecular Tools

Animal Models

Cellular Models

Cross-References

Related Genes

Related Proteins

Related Mechanisms